PANTOPRAZOLE SODIUM I.V. (PANTOPRAZOLE SODIUM)
PANTOPRAZOLE SODIUM I.V. (PANTOPRAZOLE SODIUM) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: PANTOPRAZOLE SODIUM I.V.; Generic name: PANTOPRAZOLE SODIUM; Manufacturer: Piramal Critical Care.
| Brand name | PANTOPRAZOLE SODIUM I.V. |
|---|---|
| Generic name | PANTOPRAZOLE SODIUM |
| Manufacturer | Piramal Critical Care |
| Used for | 1 INDICATIONS AND USAGE Pantoprazole sodium for injection is indicated for treatment of: gastroesophageal reflux disease (GERD) and a history of erosive esophagitis (EE) for up to 10 days in adults. pathological hypersecretion conditions including Zollinger-Ellison (ZE) Syndrome in adults. Limitations of Use The safety and effectiveness of pantoprazole sodium for injection for the treatment of upper gastrointestinal bleeding have not been established in adult or pediatric patients. Pediatric use information is approved for Pfizer Inc.’s PROTONIX ® I.V. (pantoprazole sodium) for Injection. However, due to Pfizer Inc.’s marketing exclusivity rights, this drug product is not labeled with that i |
| Dosage | 2 DOSAGE AND ADMINISTRATION . GERD and a History of EE Adults: • The recommended dosage is 40 mg once daily by intravenous injection (over at least 2 minutes) or intravenous infusion (for 15 minutes) for up to 10 days. ( 2.1 ) • Discontinue as soon as the patient is able to receive oral treatment. Switch to an appropriate oral medication within 10 days of starting pantoprazole sodium for injection. ( 2.1 ) Pathological Hypersecretion Conditions, Including ZE Syndrome • The recommended adult dosa |
| Active ingredient(s) | PANTOPRAZOLE SODIUM |
| Route | INTRAVENOUS |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0696b10c-972b-9dcf-e063-6294a90a1034 |